Aerosol deposition in the human lung: effect of high-frequency oscillation on the deposition characteristics of an inhaled nebulized aerosol
- PMID: 3254767
- DOI: 10.1042/cs0750535
Aerosol deposition in the human lung: effect of high-frequency oscillation on the deposition characteristics of an inhaled nebulized aerosol
Abstract
1. Oral high-frequency oscillation (OHFO) may have important effects on aerosol deposition in the lungs. In order to investigate these, a technique was devised to measure regional deposition rates of a nebulized radiolabelled aerosol in the lungs during normal tidal breathing. 2. The effect of three frequencies of OHFO on pulmonary aerosol deposition rate (PADR) in four normal subjects and five patients with chronic airways obstruction (CAO) were assessed using the technique. 3. In separate experiments employing three normal subjects, the effect of OHFO was studied on the deposition rate of aerosol on the oropharynx and delivery apparatus, and on the amount and characteristics of aerosol inhaled by the subjects. 4. Total PADR was significantly reduced by OHFO at 8 Hz and 16 Hz in the normal subjects, and by all three frequencies of OHFO in the CAO patients. In the normal subjects, the regional distribution of aerosol deposition was unchanged, but in the CAO patients a larger proportion of total aerosol deposition occurred in peripheral lung. 5. OHFO reduced the oropharyngeal aerosol deposition rate, increased the loss of aerosol to the atmosphere before inhalation, and increased the deposition of aerosol on the delivery apparatus. The end result was a reduction in the amount of aerosol inhaled, and in the particle sizes measured at the mouthpiece. 6. We conclude that OHFO reduces the amount of aerosol inhaled, but may improve peripheral deposition of inhaled aerosol in patients with CAO. This effect may be of value in the clinical administration of nebulized drugs.
Similar articles
-
Ventilatory saving by external chest wall compression or oral high-frequency oscillation in normal subjects and those with chronic airflow obstruction.Clin Sci (Lond). 1985 Sep;69(3):349-59. doi: 10.1042/cs0690349. Clin Sci (Lond). 1985. PMID: 4064575 Clinical Trial.
-
Oropharyngeal deposition of 3.5 microns particles inhaled through an elongated mouthpiece.Eur Respir J. 1996 Jul;9(7):1556-9. Eur Respir J. 1996. PMID: 8836672
-
Direct write-out of particle size distribution of inhaled aerosol deposition using a laser scattering method.Respir Physiol. 1989 Oct;78(1):107-21. doi: 10.1016/0034-5687(89)90146-1. Respir Physiol. 1989. PMID: 2813984
-
Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998.Respir Med. 1999 Feb;93(2):123-33. doi: 10.1016/s0954-6111(99)90302-5. Respir Med. 1999. PMID: 10464864 Review.
-
Aerosol deposition considerations in inhalation therapy.Chest. 1985 Aug;88(2 Suppl):152S-160S. doi: 10.1378/chest.88.2_supplement.152s. Chest. 1985. PMID: 3893925 Review.
Cited by
-
A radiometric study of factors affecting drug output of jet nebulizers.Indian J Pharm Sci. 2010 Jan;72(1):31-8. doi: 10.4103/0250-474X.62234. Indian J Pharm Sci. 2010. PMID: 20582187 Free PMC article.
-
The science of nebulised drug delivery.Thorax. 1997 Apr;52 Suppl 2(Suppl 2):S31-44. doi: 10.1136/thx.52.2008.s31. Thorax. 1997. PMID: 9155849 Free PMC article. Review. No abstract available.
-
Airway clearance techniques for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD008328. doi: 10.1002/14651858.CD008328.pub2. Cochrane Database Syst Rev. 2012. PMID: 22419331 Free PMC article.
-
Pulmonary deposition of a nebulised aerosol during mechanical ventilation.Thorax. 1993 Feb;48(2):154-9. doi: 10.1136/thx.48.2.154. Thorax. 1993. PMID: 8493630 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources